Latest ArticlesTremor is defined as an involuntary, rhythmic and oscillatory movement in a body part. New consensus criteria for classifying tremor disorders were published by the task force on tremor of International Parkinson and Movement Disorder Society (IPMDS) in 2017, which classified tremor along two axes: clinical characteristics (axis 1) and etiology (axis 2). This classification scheme retains the currently accepted tremor syndromes, including essential tremor, and provides a framework for defining new syndromes. This paper is the interpretation of IPMDS statement.
Parkinson's disease is a common chronic degenerative disease of the nervous system, which brings not only sufferings to patients, but also heavy burden to family and society. It is necessary to manage the Parkinson's disease effectively. In 2017, British National Institute for Health and Care Excellence published Parkinson's disease in adults: diagnosis and management. In order to explain the guideline briefly, this article provides an interpretation reference for the treatment of Parkinson's disease in China.
Multiple system atrophy (MSA) is a neurodegenerative disease with onset and progressive development in the middle and old age, which has rapid progress and poor prognosis. MSA has various clinical manifestations, mainly atypical autonomic dysfunction or sleep disorders, and motor symptoms. Generally, the early identification of MSA and other neurodegenerative diseases can be performed through the combination of neuroimaging with autonomic nerve function tests. At present, the MSA has no specific treatment. However, some medication and physiotherapy can improve the life quality of patients. This article reviews the clinical diagnosis and treatment of MSA.
Dementia syndromes associated with Lewy body are subdivided into dementia with Lewy body (DLB) and Parkinson's disease dementia (PDD). Despite considerable neuropathological and clinical overlap, their diagnosis is based on the onset time of motor and cognitive symptoms. Generally, the dementia onset is preceding parkinsonism called as DLB, and the onset of cognitive impairment is after the onset of motor symptoms called as PDD, and there are still a lot of controversies about the nosology and pathogenesis of both syndromes. This article describes the clinical research progress of both DLB and PDD based on the clinical criteria, neuropathology and pharmacotherapy.
Cardiovascular autonomic dysfunctions, including neurogenic orthostatic hypotension, supine hypertension and post-prandial hypotension, are relatively common in the patients with Parkinson's disease (PD), some of which even occur prior to the appearance of the typical motor deficits associated with the disease. When cardiovascular autonomic dysfunction develops, the patients with PD have an increased mortality risk, falls, and trauma-related to falls. This review describes the pathophysiology of cardiovascular autonomic dysfunction in PD and its therapy.
To investigate the effect of traditional Chinese medicine Ziyedan capsule on the rats cirrhosis induced by diethylnitrosamine (DEN).
A total of 120 Wistar rats were randomly divided into treatment group, model group and normal group, with 40 rats in each group. The rats in the treatment group and the model group were injected with DEN, and the treatment group was administered with Ziyedan capsule (0.781 g/kg) for 16 weeks. The expression of type Ⅰ and Ⅲ collagen and transforming growth factor-β1 (TGF-β1) mRNA in liver disease and liver tissue and body weight were observed at 4th, 8th, 12th and 16th week.
①Compared with the normal group, body weights in model group and treatment group were decreased (P<0.01). ②Compared with the model group, the fibrosis score of the treatment group at 12th week was decreased (P<0.01). ③Compared with the model group, the expressions of type Ⅰ and Ⅲ collagen mRNA in the treatment group at 4th, 8th, 12th and 16th week were significantly decreased (P<0.01). The expression of TGF-β1 mRNA was significantly decreased at 12th, and 16th week (P<0.01).
Ziyedan capsule can inhibit the formation of cirrhosis induced by DEN in Wistar rats. Its mechanism may be related to the down-regulation of the expression of type Ⅰ, Ⅲ collagen and TGF-β1 mRNA.
To observe the efficacy of the Qingfei Quzhi decoction combined with fusidic acid cream in the treatment of mild-to-moderate acne vulgaris.
Sixty patients with acne vulgaris were divided into treatment group (n=30) and control group (n=30). The treatment group was given with Qingfei Quzhi decoction and fusidic acid cream, and the control group was treated with Danshentong capsule and fusidic acid cream. The numbers of papules, pustules, non-inflammatory lesions were recorded before treatment, and the 2 weeks, 4 weeks and 6 weeks after treatment. The blood flow velocity of skin lesions was recorded before and the 4 weeks after treatment by laser speckle contrast imaging. The contrast ratio was obtained by terminal PC, and the curative effect was evaluated quantitatively.
In the 4 weeks and 6 weeks after treatment, the numbers of papules, pustules and non-inflammatory lesions were decreased significantly in two groups (P<0.05). The numbers of papules and pustules in the 4 weeks after treatment, the numbers of papules, pustules and non-inflammatory lesions in the 6 weeks after treatment in treatment group were less those in control group (P<0.05). The total effective rate (96.67%) in treatment group was equivalent to that in control group (90.00%, P>0.05). The contrast ratios of two groups in the 4 weeks after treatment were significantly lower than those of before treatment (P<0.05), but there was no significant difference between two groups (P>0.05). No serious adverse drug reactions related to medication was found in the two groups.
Qingfei Quzhi decoction combined with fusidic acid cream is effective in the treatment of acne vulgaris with little side effects. Laser speckle contrast imaging plays a guiding role in objective and quantitative evaluation of acne curative efficacy, which is worth to be spread.
To find the correlation of the quality of life in psoriasis vulgaris patients with varies traditional Chinese medicine (TCM) syndrome differentiation, to provide theoretical evidence and treatment idea for the TCM doctors to take holistic treatment for psoriasis vulgaris patients.
Total of 101 cases of psoriasis vulgaris patients were selected and divided into blood heat syndrome group, blood stasis syndrome group and blood dryness syndrome group according to TCM syndrome differentiation by one or more of the dermatologists of TCM. The psoriasis disability index (PDI) and dermatology life quality index (DLQI) were used to evaluate the patients, and the total scores of PDI and DLQI, and the scores of each dimension of PDI and DLQI in each group were compared.
Compared with the blood heat syndrome group, the total DLQI score in blood stasis syndrome group, the total PDI score and the total DLQI score in blood dryness syndrome group were lower (P<0.01). The PDI scores of each dimension showed that, except for the treatment dimension score, the difference of the other dimension scores between the blood heat syndrome group and the blood dryness syndrome group were statistically significant (P<0.05). The difference of the daily work dimension score between the blood heat syndrome group and the blood stasis syndrome group was statistically significant (P<0.01). The DLQI scores of each dimension showed that, compared with blood heat syndrome group, each dimension scores in blood dryness syndrome group were lower (P<0.05 or P<0.01), the daily life and work learning dimension scores in blood stasis syndrome group were lower (P<0.05 or P<0.01), and the difference of the symptom feeling dimensions score between the blood stasis syndrome group and the blood dryness syndrome group was statistically significant (P<0.05).
The TCM syndrome differentiation in psoriasis vulgaris patients is related with their quality of life. The life quality of the patients with blood heat syndrome is worse than that in blood stasis and blood dryness syndrome patients.
To observe the clinical effect of the Gushen Antai decoction combined with progesterone injection on the patients with fetal leakage and fetal irritability with kidney deficiency.
Seventy-four patients with fetal leakage and fetal irritability with kidney deficiency were randomly divided into observation group and control group as 37 cases in each group. The control group was treated with progesterone injection (intramuscular injection, 20 mg each time, twice a day). On the basis of the control group, the observation group was additionally treated with Gushen Antai decoction (orally, one dose a day, twice a day), as 5~7 days a course. The general data (age, pregnancy week, course of treatment, frequency of abortion), total score of traditional Chinese Medicine (TCM) symptoms, laboratory indexes [serum human chorionic gonadotropin (β-HCG), progesterone level] and follow-up outcome (the condition of eutocia, abortion and recrudescence) before and after treatment were analyzed and compared between two groups.
Compared with before treatment, the β-HCG and progesterone level after treatment in two groups were increased (P<0.05 or P<0.01). The β-HCG and progesterone level in observation group were higher than those in control group (P<0.05). Compared with before treatment, the total score of TCM symptoms after the treatment in two groups were decreased, but the difference was statistically significant only in observation group (P<0.01). Compared with the control group, the total score of TCM symptoms of the observation group was lower (P<0.05). The patients with recrudescence, the second recrudescence, and abortion in observation group were less than those in control group, but the patients with eutocia were more (P<0.01).
Gushen Antai decoction combined with progesterone injection in the treatment of fetal leakage and fetal irritability with kidney deficiency can improve patients' β-HCG and progesterone level, and obviously reduce the recrudescence and abortion.
To explore the effect of compound glycyrrhizin on viral load and liver function in the hepatitis children caused by EB virus (EBV) infection.
A total of 108 cases of children with EBV infection hepatitis in our hospital from August 2015 to January 2017, who were randomly divided into control group and observation group, as 54 cases in each group. The control group was treated with ganciclovir (5 mg/kg, once a day) plus reduced glutathione (GSH, 0.3 g or 0.6 g, once a day). On this basis, the observation group was additionally treated with compound glycyrrhizin injection (1 ml/kg, once a day). Both groups were treated for 2 weeks. The incidence of adverse drug reactions, and the EBV load, liver function and T lymphocyte subsets levels before and after the treatment in two groups were compared.
Compared with before treatment, the EBV-DNA copy number, serum ALT, AST and AKP, CD3+, CD4+, CD8+ and CD4+/CD8+ in two groups were improved in varying degrees, and the differences were statistically significant (P<0.05 or P<0.01). After treatment, the peripheral blood EBV-DNA copy number, serum ALT, AST and AKP, CD3+ and CD8+ of the observation group were significantly lower than those of control group (P<0.05 or P<0.01), the CD4+ and CD4+/CD8+ of observation group were higher than those of control group (P<0.05). The incidence rate of adverse drug reactions had no difference between two groups (P>0.05).
Compound glycyrrhizin can reduce viral load and promote the recovery of liver function in the hepatitis children caused by EBV infection, and improve immune function with less adverse drug reactions.